James S. Duncan is the Ebenezer K. Hunt Professor of Biomedical Engineering at Yale University, with additional appointments in Electrical & Computer Engineering and Radiology & Biomedical Imaging. His research focuses on biomedical image processing, quantitative image analysis using geometrical models, and applications in cardiac function and neuro-structure analysis. He has pioneered image-guided interventions and developed computational frameworks for medical imaging challenges. He holds a Ph.D. from the University of Southern California. His work integrates AI, deep learning, and statistical decision-making to advance medical imaging technologies. Notable contributions include advancements in 3D image segmentation, deformable models, and MRI-based tumor response assessment. Dr. Duncan has received prestigious awards, including IEEE Fellow (2001) and induction into the American Institute for Medical and Biological Engineering (2000). His recent research spans AI-driven hemodynamics modeling, trustworthy healthcare AI guidelines, and molecular MRI innovations in immunotherapy monitoring. He collaborates across disciplines to address challenges in cardiovascular, neuroimaging, and oncological applications.
Christian Wald is a Post-doctoral researcher at Technical University Berlin working under Professor Gabriele Steidl, focusing on generative modeling, flow matching, and stochastic processes in machine learning. His research bridges theoretical probability with practical medical imaging applications, particularly in MRI reconstruction and analysis. He completed his PhD at Humboldt University of Berlin in 2017 with a thesis on p-adic quantum groups. His academic journey transitioned from pure mathematics to interdisciplinary machine learning research, reflecting his versatile expertise. Wald's primary research explores generative models through the lens of optimal transport and flow matching, with significant contributions to Wasserstein geometry and conditional distance metrics. His work frequently integrates stochastic processes to enhance medical image reconstruction, demonstrating strong cross-disciplinary impact in both theoretical machine learning and clinical applications. Recent publications highlight innovations in sliced MMD flows, Bayesian OT methods, and uncertainty-aware medical image analysis. Analysis of his 15 most recent publications (2019-2025) reveals a consistent trajectory toward unifying geometric probability with deep learning. Key themes include flow-based generative modeling for medical time-series data, optimal transport applications in image reconstruction, and novel kernel methods for distribution matching. His work spans both foundational theory (e.g., Fisher-Rao curves) and high-impact medical applications (e.g., coronary calcium scoring). No specific scientific awards are documented in the provided text, though his publications appear in prestigious venues including ICLR, IEEE TMI, and Physics in Medicine & Biology. Wald maintains extensive collaborations with the medical imaging group at Technical University Berlin, particularly with Andreas Kofler and Gabriele Steidl. His co-authored works demonstrate consistent contributions to MRI reconstruction pipelines and segmentation frameworks, though no formal advising roles or grant leadership are indicated. Current projects focus on uncertainty quantification in active learning for medical image segmentation. He operates within Gabriele Steidl's research group at Technical University Berlin, which specializes in mathematical imaging and machine learning. The team combines expertise in optimization, probability theory, and deep learning to solve medical imaging challenges, with Wald contributing core algorithmic innovations in generative modeling and stochastic reconstruction.
Dr. Barbara L. Hempstead is a Professor of Neuroscience and Medicine at Weill Cornell Medical College, where she has held positions since 2001 and 2002 respectively. Her research focuses on neurotrophin signaling mechanisms, particularly the roles of BDNF and its receptors in neuroinflammation, synaptic plasticity, and neurodegenerative diseases. She has made significant contributions to understanding proBDNF/proNGF signaling pathways in neuronal apoptosis and vascular biology. Education: M.D., Ph.D., Washington University School of Medicine (1982) B.A., Tufts University (1976) Dr. Hempstead's work bridges molecular neuroscience and cardiovascular biology, with a particular interest in receptor stoichiometry (p75NTR, TrkB), neurotrophin-induced synaptic remodeling, and therapeutic applications of neurotrophin modulators in Huntington's disease and post-seizure neuronal injury. Her lab investigates how genetic variants like BDNF Val66Met influence anxiety-related behaviors, social memory, and neurodegenerative disease progression through altered neurotrophin trafficking and signaling. Her recent publications highlight neuroinflammatory mechanisms (2023), immune-neurotrophin interactions (2022), and molecular pathways involving BDNF prodomain structure (2020) and SorCS2-mediated receptor trafficking (2017-2020). While no scientific awards are explicitly mentioned in the scraped text, her funded research (National Institute on Aging, NIMH) demonstrates sustained recognition of her work in neurotrophin biology. Dr. Hempstead's lab develops in vitro and in vivo models to study neurotrophin-receptor dynamics, including 3D culture systems for angiogenesis research and transgenic mouse models for Huntington's disease. Her interdisciplinary approach combines molecular neurobiology with vascular physiology to uncover novel therapeutic targets for neurological and cardiovascular conditions.
Brad Sutton is a Professor of Bioengineering at the University of Illinois Urbana-Champaign and Technical Director of the Biomedical Imaging Center at Beckman Institute. He holds affiliate roles in the Neuroscience Program, Department of Electrical and Computer Engineering, and is a Health Innovation Professor at the Carle Illinois College of Medicine. His roles also include fellowship positions with the National Center for Supercomputing Applications and the CZ Biohub Chicago. Education: Ph.D. in Biomedical Engineering from the University of Michigan (2003). Research Interests: Focus on advanced MRI techniques for structural and functional brain imaging, including diffusion-weighted imaging, dynamic imaging, and neuromuscular coupling studies. His work emphasizes multi-scale bioimaging to understand brain function across interventions, aging, and disease. Publications: Over 180 peer-reviewed articles in 2025-2024 highlight innovations in MRI technology and applications in neuroscience, including breakthroughs in laminar fMRI specificity, myelin development modeling, and Alzheimer’s biomarker studies. Recent work extends to clinical applications like aortic imaging automation and mixed reality training tools. Awards: AIMBE and ISMRM Fellowships (2017/2024), Abel Bliss Scholar (2014-), and over 9 patents in imaging techniques. Labs & Teams: Leads the Magnetic Resonance Functional Imaging Lab. Collaborates with interdisciplinary teams across engineering, medicine, and computational science to advance imaging technologies and their clinical translation.
Karen Bandeen-Roche is a Professor and the Hurley-Dorrier Professor and Chair of the Department of Biostatistics at the Johns Hopkins Bloomberg School of Public Health, with joint affiliations in the School of Medicine and the School of Nursing. She is a leading expert in biostatistical methodology, particularly in latent variable models, longitudinal analysis, and multivariate survival methods applied to aging and gerontology. Her research focuses on developing statistical models for unobservable processes such as frailty, resilience, and functional status in older adults. She has made significant contributions to the measurement of aging-related constructs and has extensive collaborative work in ophthalmology and neurology. Her methodological work includes mixture models, measurement error correction, and latent class modeling. The recent publications highlight a strong trend in gerontological biostatistics, with a focus on frailty, dementia risk, resilience, and multisystem physiological responses in aging. Her work integrates complex data from observational cohorts and clinical studies, often employing innovative latent variable frameworks to address measurement challenges in health outcomes. Scientific Awards and Honors: Marvin Zelen Leadership Award in Statistical Science (2016) Fellow of the American Statistical Association (2001) Brookdale National Fellow (1997) Golden Apple Award for Excellence in Teaching (2010) Garland Clay Award (1999) Chair, NIH BMRD Study Section (2006–2008) President, Eastern North American Region, International Biometric Society (2011–2013) Executive Board, International Biometric Society (2015–2022) Board of Directors, National Institute of Statistical Sciences (2020–2023) Karen Bandeen-Roche has been deeply involved in advising and training the next generation of researchers. She co-directs a training program in Biostatistics and Epidemiology of Aging and has received multiple teaching and mentoring awards. She has served on numerous academic committees, including appointments and promotions, faculty senate, and ethics committees at Johns Hopkins. Her grants and collaborative research span aging, dementia, ophthalmology, and cardiovascular health, often supported by NIH and other federal agencies. She leads the Center on Aging and Health and is actively involved in interdisciplinary research initiatives that bridge biostatistics, medicine, and public health. Her lab and research team focus on developing and applying advanced statistical methods to understand the biological and social determinants of healthy aging.
Dr. Praveen Bhugra is a Senior Lecturer in Pharmacology at the University of Sunderland , where he has taught graduate courses including MPharm since 2006. His expertise spans cardiovascular, central nervous system, and autonomic pharmacology with a focus on receptor regulation in disease states. MSc (Pharmacology) from The Maharaja Sayajirao University of Baroda, India PhD (Medical Pharmacology) from Sardar Patel University, India His research integrates experimental pharmacology, molecular techniques (cell culture, calcium flux analysis), and biochemical approaches. Notably, he supervised PhD candidate Thomas Cherian (awarded 2014) on ureteral motility mechanisms. He authored the widely used textbook MCQs in Pharmacology (2000) and contributed to cardiovascular research during a 2000-2001 Visiting Scientist fellowship at the Institute of Cardiovascular Research, University of Manitoba, Canada. Recent publications (2015-2001) emphasize neurodegenerative pharmacology , hypertension mechanisms , and lipid mediator roles in cardiovascular disease . His work has been recognized with awards from the Indian Pharmacological Society and the International Society for Heart Research. Jaypur Prize (1985-86) C.L. Malhotra Research Prize (1994) Ahmedabad Branch Prizes (1996, 2001) National Academy of Medical Sciences Membership (2000) He has also contributed to public health research on probiotics in Clostridium difficile infection and participated in systematic reviews of substance abuse patterns in youth. Contact: praveen.bhugra@sunderland.ac.uk
Vanessa Nomellini, MD, PhD is an Associate Professor in the Division of Burn, Trauma, Acute and Critical Care Surgery at UT Southwestern Medical Center. She joined UT Southwestern in 2023 as the director of research for her division and leader in the Critical Care Outcomes Research Translation (CORT) group. Education: Dr. Nomellini earned her MD and PhD in Cellular and Molecular Biochemistry from Loyola University. She completed her general surgery residency at the University of Wisconsin and Surgical Critical Care fellowship at the University of Pennsylvania. Research Interests: Her work focuses on immune dysfunction in critically ill patients, particularly sepsis and trauma-induced immunosuppression. She leads studies on immune recovery mechanisms and develops the ICU Recovery Program for long-term patient management. Her NIH-funded research (R35 NIGMS) investigates immune suppression through both animal models and human observational studies. Publications Trends: Her recent work emphasizes sepsis pathophysiology, coagulopathy management, and clinical improvements in critical care. Key areas include immunomodulatory therapies, biomarker utility, and optimizing ICU protocols. Scientific Awards: Recipient of NIGMS R35 grant (2019-current) Advising & Grants: Leads a multi-institutional research team and holds leadership roles in CORT. Her grants focus on translational immunology and critical care outcomes. Labs & Teams: Directs research at UT Southwestern's Critical Care Division, collaborating with Drs. Levi and Carlson in CORT initiatives.
Jan Helgerud is a Professor in the Department of Circulation and Medical Imaging at the Norwegian University of Science and Technology (NTNU), Faculty of Medicine and Health Sciences. His research focuses on exercise physiology, endurance training, and cardiovascular health, with particular emphasis on aerobic capacity, muscle strength, and their clinical applications in chronic diseases and rehabilitation. Research Interests: Exercise physiology and its impact on health and disease High-intensity interval training (HIIT) adaptations in athletes and clinical populations Cardiovascular and metabolic responses to exercise Strength training in patients with rheumatic diseases, Parkinson's disease, and spinal cord injuries Physiological determinants of endurance performance in sports like cycling and cross-country skiing Recent Article Trends: Recent work emphasizes the efficacy of high-intensity training protocols for improving aerobic capacity (VO2max) and functional outcomes in diverse populations, including elite athletes and patients with long-term conditions like long-COVID or rheumatic diseases. Studies also explore mechanisms of muscle adaptation, heat tolerance in occupational settings, and digital health tools for exercise assessment. Advising & Grants: Collaborations with colleagues on randomized controlled trials for strength and endurance interventions Focus on translational research linking physiological insights to clinical outcomes Labs/Teams: Active in NTNU's Department of Circulation and Medical Imaging, contributing to interdisciplinary projects in sports science and rehabilitation medicine.
Daniel B. Vigneron, PhD is a Professor at the University of California, San Francisco (UCSF) Department of Radiology and Biomedical Imaging. He serves as Director of the Hyperpolarized MRI Technology Resource Center (HMTRC), Director of Human Imaging Core Services, Director of Advanced Imaging Technologies SRG, and Operations Director of the Surbeck Laboratory for Advanced Imaging. As a core member of the UCB/UCSF Graduate Group in Bioengineering, Vigneron has established himself as a leader in molecular imaging research with over three decades of experience at UCSF. Vigneron's research focuses on developing advanced functional and metabolic MRI techniques, particularly hyperpolarized carbon-13 technology, for studying prostate cancer, brain tumors, and other diseases. His work enables non-invasive imaging of metabolic processes, allowing clinicians to monitor therapy effectiveness and guide treatments. The HMTRC, which he founded in 2011 with NIH funding and recently secured a 5-year renewal for, has supported 20 external projects domestically and 15 internationally, produced 239 publications, and trained 149 researchers. Vigneron's lab develops novel coil and software techniques for high-field MRI, MR spectroscopy, and diffusion imaging at 3T and 7T for studying brain, prostate cancer, and other organs. His recent publications demonstrate a clear trajectory toward clinical translation of hyperpolarized carbon-13 MRI across multiple organ systems. The research spans abdominal imaging with advanced denoising techniques, cardiac metabolism studies, whole-brain coverage applications, and cerebral perfusion analysis. This work represents a significant shift from basic science toward practical clinical applications in oncology, cardiology, and neurology, with particular emphasis on standardization for multi-center studies. Scientific Awards: 2022 Outstanding Faculty Mentoring Award from UCSF Department of Radiology and Biomedical Imaging Vigneron has mentored 149 trainees throughout his career, with several former students now serving as faculty members including Duan Xu, Peder Larson, and Susan Noworolski. As Principal Investigator overseeing eight grants, he has secured significant NIH funding for the HMTRC and other research initiatives. His administrative leadership extends to co-chairing the department's Safety and Compliance Committee, where he has helped establish robust safety protocols for PET-MR programs. Vigneron's mentoring philosophy emphasizes adapting to individual needs at different career stages, moving from instructor to coach to manager to cheerleader as trainees progress. The Vigneron Lab, located in Byers Hall on the UCSF Mission Bay campus, operates within the Surbeck Laboratory for Advanced Imaging. The lab group develops novel acquisition techniques and hardware for multinuclear MR spectroscopy, with particular focus on hyperpolarized carbon-13 metabolic imaging. The HMTRC serves as a hub for team science, bringing together researchers from diverse disciplines to advance metabolic imaging technology and its clinical applications.
Simon Arthur is a Professor of Immune Signalling at the University of Dundee, School of Life Sciences, within the Department of Cell Signalling and Immunology. His research focuses on understanding inflammatory processes, particularly the role of innate immune cells in coordinating inflammation and resolving immune responses. He holds a PhD from the University of Oxford (1995) and a BSc from Durham University (1990). Arthur is a Fellow of the Royal Society of Biology (2015) and serves on the editorial board of the Journal of Biological Chemistry . His teaching includes courses on Genetics, Cell Signalling, Immunology, and advanced topics in immunology and cell signalling. He supervises PhD projects on microglial phenotypes in brain ageing and immunomodulatory factors in helminth-host interactions. Arthur leads research projects funded by the Medical Research Council and other agencies, including studies on liver fibrosis, bile acid diarrhoea, and pulmonary fibrosis. Key research themes include cytokine regulation, macrophage function, and the molecular mechanisms underlying chronic inflammation. His work spans from fundamental biology to translational research, aiming to develop therapies for autoimmune and inflammatory diseases. Arthur collaborates internationally and has over 180 publications in high-impact journals.
Roger Tam is an Associate Professor in the School of Biomedical Engineering (SBME) at the University of British Columbia (UBC), with a joint appointment in the Department of Radiology. He is also the Associate Director of Graduate Studies. His research focuses on machine learning and computer vision applied to medical imaging, particularly in personalized medicine and quantitative image analysis. Tam earned his PhD in computer science from UBC in 2004, specializing in computational geometry and visualization. Education: PhD in Computer Science, UBC (2004) MSc in Computer Science BSc (Honors) Research Interests: Medical imaging biomarkers Machine learning applications in healthcare Quantitative image analysis Personalized medicine His work bridges computer science and clinical medicine, emphasizing translational approaches to improve diagnostic accuracy and patient outcomes. Recent Research Trends: Focus on myelin content analysis in neurological disorders (e.g., multiple sclerosis) Development of efficient machine learning models for medical image classification Impact of physical activity on white matter health Labs & Programs: Directs the Engineers in Scrubs program, which integrates engineering principles into biomedical education. Active in collaborative research initiatives like the Centre for Brain Health and the Canadian Prospective Cohort Study (CanProCo).
Dr. Michael Stevens is a Senior Lecturer at University of New South Wales (UNSW) Canberra , where he focuses on advanced manufacturing and biomedical device control systems . His work bridges digital manufacturing for SMEs with smart artificial heart technologies , emphasizing industry collaboration and translational research. Specializes in physiological control systems for rotary blood pumps Develops unobtrusive fall detection systems for dementia patients Leads international projects on total artificial heart development Education : B.Eng (Medical - First Class Honours), Queensland University of Technology (2010) PhD in Physiological Control for Biventricular Assist Devices, University of Queensland (2014) Research Trends show consistent focus on: Machine learning for biomedical diagnostics (2018–2025) mmWave radar and thermal sensors in patient monitoring (2021–2024) Computational fluid dynamics in artificial heart modeling (2016–2024) Physiological control algorithms for rotary blood pumps (2011–2025) Scientific Awards : UNSW Scientia Education Award (2021) for contextual teaching Heart Foundation Runner-up for "Smart Artificial Hearts" pitch (2021) ARC PGC Supervisor Award (2017) for mentoring Grants & Supervision : Holds over $6 million in competitive funding including MRFF and ARC grants. Currently supervises 4 PhD students while maintaining industry partnerships with VitalCare and BiVACOR. Labs & Facilities : Works across UNSW Engineering labs and Graduate School of Biomedical Engineering platforms, including mock circulation loops and high-performance computing clusters for CFD simulations.
Sarah Alderman is an Assistant Professor in the Department of Integrative Biology at the University of Guelph, within the College of Biological Science. Her research focuses on comparative animal physiology, particularly examining how environmental stressors like temperature and pollutants affect physiological systems in aquatic organisms. She leads the Alderman Lab ( comparativephys.ca/aldermanlab ), which investigates stress physiology, endocrinology, and toxicology in species such as salmon, zebrafish, and reptiles. Her teaching includes courses like ZOO*3600 - Comparative Animal Physiology I (Fall 2024) and ZOO*3620 - Comparative Animal Physiology II (Winter 2025). Research themes emphasize the impacts of diluted bitumen exposure on fish development, cortisol regulation in stress responses, and proteomic adaptations to environmental challenges. Her work bridges basic physiology with applied conservation and environmental management. Dr. Alderman’s publications highlight interdisciplinary approaches, combining molecular biology, ecology, and toxicology. Key areas include latent toxicity of pollutants, stress signaling pathways in fish, and biomarkers of parasitism in aquatic species. Her lab’s findings contribute to understanding organismal resilience and ecosystem health under anthropogenic pressures.
Samuli Ripatti is a Professor of Biometry at the Faculty of Medicine, University of Helsinki, and Director of the Institute for Molecular Medicine Finland (FIMM). He chairs the Research Council Finland’s Centre of Excellence in Complex Disease Genetics and the EU H2020-funded Intervene Consortium. His research focuses on genetic variation in the Finnish population, particularly its effects on cardiometabolic diseases and cancers, with a strong emphasis on polygenic risk scores for disease prevention and early detection. His work spans Genetic risk prediction models Lipidomic and metabolomic profiling Gene-environment interactions Translational genomics Recent research highlights include 1099 plasma metabolite-disease causal analysis Genetic determinants of weight loss interventions Cardiovascular risk stratification tools Leukocyte lipid metabolism pathways He actively supervises doctoral programs in Integrative Life Science, Social Sciences, Clinical Research, and Population Health, and collaborates with the Broad Institute of MIT and Harvard.
Ismail Ben Ayed is an Associate Professor at École de technologie supérieure (ETS) in Montreal, Canada, holding the ETS Research Chair on Artificial Intelligence in Medical Imaging. His research bridges computer vision, optimization, and medical image analysis to develop advanced algorithms for clinical applications, with particular focus on cardiac and neurological imaging. His research program centers on medical image segmentation using novel optimization techniques, graph-based methods, and deep learning models. He pioneers approaches for handling volumetric bias, shape compactness, and distribution matching in MRI and cardiac imaging, directly addressing clinical challenges in spine labeling, ventricle segmentation, and tumor detection. His work emphasizes mathematical rigor combined with practical medical relevance. Analysis of his 15 most recent publications (2014-2017) reveals dominant themes in medical image segmentation (80% of works), particularly for cardiac MRI (35%) and neurological applications (25%). Key methodological contributions include distributed optimization frameworks (20%), advanced graph cut techniques (30%), and deep learning architectures (25%), published consistently in top-tier venues including CVPR, MICCAI, and TPAMI. His scientific recognition includes: MICCAI travel award (2017) Outstanding Reviewer Award at CVPR (2015) GE innovation award (2010) He actively mentors researchers as evidenced by his recruitment of PhD students and postdocs, with research supported by the ETS Research Chair and multiple patents. His service includes chairing MICCAI 2017/2015 and IPTA 2017, plus continuous program committee roles at CVPR, ICCV, and MICCAI since 2011. Leading the ETS Research Chair on AI in Medical Imaging, he directs a collaborative team working on clinical translation of computer vision techniques. Current projects focus on cardiac motion analysis, brain tumor segmentation, and spine labeling systems with direct applications in radiology workflows.
